Usana Health Sciences Accounts Payable

Usana Health Sciences (USNA) currently reports a accounts payable of $15M as of July 2026. That compares with $18M in the prior-year period — down 13.8% year over year. Use the charts on this page to explore Usana Health Sciences's accounts payable history and peer comparisons.

Usana Health Sciences's accounts payable decreased from $18M to $15M — a 13.8% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Usana Health Sciences reported $15M in accounts payable as of July 2026. That compares with $18M in the prior-year period — down 13.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Usana Health Sciences, and consider following USNA for alerts when major investors trade the stock.

Usana Health Sciences is classified in the Healthcare sector. On accounts payable, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing USNA with unrelated industries.